Biotech Stocks To Research – February 08th

Today, five biotech stocks are highlighted for potential research: Danaher, Thermo Fisher Scientific, Cencora, AbbVie, and Illumina. These stocks are notable based on their high dollar trading volume over the past few days. Biotech stocks are associated with companies engaged in the research, development, and commercialization of products and technologies in the biological realm, especially within healthcare, pharmaceuticals, and agriculture. The performance of these stocks is often driven by the outcomes of clinical trials, regulatory approvals from the FDA, and other key developments within the biotech sector.

Danaher (DHR)

Danaher Corporation operates globally, creating a range of professional, medical, industrial, and commercial products and services. Its biotechnology division focuses on advancing the development and manufacture of therapeutics, offering technologies like bioprocess solutions, cell culture media, and filtration technologies. As of Friday, Danaher shares fell by $3.09, settling at $206.92, with a total trade volume of 5,230,603 shares. The company's market capitalization stands at $149.45 billion, accompanied by a price-to-earnings (P/E) ratio of 39.19 and a beta of 0.83.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. is a leader in life sciences solutions, providing analytical instruments, diagnostic products, and lab services worldwide. Their Life Sciences segment supplies essential tools and reagents vital for drug and vaccine production, alongside diagnostic solutions for diseases. On Friday, TMO traded at $571.44, down $1.27, with a trading volume of 1,826,939 shares. The company has a P/E ratio of 34.57 and a market cap of $218.58 billion.

Cencora (COR)

Cencora, Inc. specializes in the sourcing and distribution of pharmaceutical products. Its U.S. Healthcare Solutions division extends a variety of healthcare products to hospitals, pharmacies, and clinics, among others. Cencora's stock grew $1.81 to reach $247.94 during midday trading on Friday, with 3,815,513 shares exchanged. The current market cap is $47.92 billion, with a P/E ratio of 35.27.

AbbVie (ABBV)

AbbVie Inc. is a global pharmaceutical company involved in discovering and selling a range of medications, including well-known products like Humira and Rinvoq. On Friday, AbbVie shares decreased by $2.30 to $190.67, with a trading volume reaching 3,805,381. AbbVie currently has a market capitalization of $336.94 billion, with a high P/E ratio of 79.45.

Illumina (ILMN)

Illumina, Inc. provides advanced solutions for genetic analysis through sequencing and array technology. The company, operating across key markets worldwide, offers various instruments and kits essential for genomic research. Illumina's shares fell $11.74 on Friday to $111.06, with a significant trading volume of 5,434,023 shares. The firm holds a market cap of $17.61 billion and shows a P/E ratio of -14.46.

stocks, biotech, investment